MarginsXMarginsX
Home › Markets › Health Care › LIVN

LivaNova PLC (LIVN)

LIVN trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$92.44
+1.23% on the day
Market cap
$5.1B
Mid cap
Revenue · 2025
$1.4B
+10.7% on 2024
Net income · 2025
-$242.5M
-17.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1639691/000163969126000010/0001639691-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerLIVN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited Kingdom
IPO yearNot reported by the screener
SEC CIK0001639691
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inUnited Kingdom

Financials · 2025

LineValue
Revenue$1.4B
Net income-$242.5M
Operating income$199.4M
Net margin-17.5%
Operating margin14.4%
Revenue growth+10.7%
Cash$635.6M
Total assets$2.6B
P/E (computed)Net income was not positive
P/S (computed)3.7×

Warning signs

Cash runway
Cash-flow positive
$563.5M cash at September 30, 2026
Share count, 1 year
+0.9%
2025-10-29 to 2026-10-28 · +2.3% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$1.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$563.5M cash; operating cash flow $59.5M a quarter.Report 2026-09-30
Shares outstanding55,086,809 (2026-10-28); 54,605,527 a year earlier; 53,870,826 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Houston, Texas, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $1.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$393.1M$34.3M$73.7M$563.5M$295.4M$1.5B10-Q 2026-11-04
Q2 2026
2026-06-30
$390.6M$108.6M$66.6M$516.6M$290.1M$1.5B10-Q 2026-08-05
Q1 2026
2026-03-31
$362.3M$22.3M$15.2M$539.7M$285.3M$1.4B10-Q 2026-05-06
Q4 2025
2025-12-31
$360.9M$30.9M$82.4M$635.6M$376.1M$1.4B10-K 2026-02-25
Q3 2025
2025-09-30
$357.8M$26.8M$85.1M$646.1M$434.5M$1.3B10-Q 2026-11-04
Q2 2025
2025-06-30
$352.5M$27.2M$62.9M$593.6M$430.6M$1.3B10-Q 2026-08-05
Q1 2025
2025-03-31
$316.9M-$327.3M$24.0M$738.4M$628.2M$1.3B10-Q 2026-05-06
Q4 2024
2024-12-31
$321.8M$55.9M$78.7M$428.9M$627.0M$1.3B10-K 2026-02-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22021-08-05
Latest annual report10-K2026-02-25
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 957 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.5%
1 month+19.6%
3 months+11.1%
Year to date+48.4%
1 year+65.4%
From 52-week high-3.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
AXGNAxogen Inc.$55.38-0.98%$3.3B
TMDXTransMedics Group Inc.$92.21+0.91%$3.2B
CNMDCONMED Corporation$49.35-2.45%$1.5B
CBLLCeriBell Inc.$26.42+1.07%$1.0B
INMDInMode Ltd.$13.15-0.90%$755.9M
CVCapsoVision Inc.$6.47+7.30%$346.9M
MDTMedtronic plc.$102.88+0.02%$131.6B
ELMDElectromed Inc.$23.10-5.02%$188.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier